Open AccessNew-Device Angioplasty in Women: Outcomes of Planned and Unplanned Use
Author(s) -
Elizabeth D. Kennard
Publication year - 2002
Publication title -
epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.901
H-Index - 173
eISSN - 1531-5487
pISSN - 1044-3983
DOI - 10.1097/00001648-200205001-00009
Subject(s) - medicine , angioplasty , balloon , coronary artery disease , myocardial infarction , revascularization , door to balloon , clinical endpoint , diabetes mellitus , percutaneous coronary intervention , randomized controlled trial , primary angioplasty , endocrinology
New interventional devices for treatment of coronary artery disease are used in planned mode for the definitive treatment of lesions with particular morphology, and in unplanned mode after failure or suboptimal conventional balloon angioplasty. This report from the New Approaches to Coronary Intervention Registry describes the baseline characteristics and short- and long-term outcomes of men (N = 840) and women (N = 721) treated with one of seven new devices in planned and unplanned modes. For both planned and unplanned attempts, women were older than the men by approximately 5 years and were more likely to have diabetes (25% vs 16%) and hypertension (64% vs 46%). Lesions treated with planned new devices were more frequently in the right coronary artery in women and in an ostial location. There were few differences seen in the lesions treated with unplanned devices. In-hospital success was good for all groups, although men with unplanned attempts fared somewhat less well than the women (procedural success 90% for women vs 79% for men). At 1 year, the combination endpoint of death/Q-wave myocardial infarction/repeat revascularization was 32% for women vs 49% for men in the unplanned group, and 32% vs 38% in the planned group.